文献速递神经儿科影像MR

脑部放疗与钆布醇给药对儿童脑肿瘤患者MRI脑信号强度的影响

Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
PubMed 文献 · Radiology · 2018-07-10

这项回顾性单中心研究纳入78例原发性脑肿瘤患儿,比较放疗组、单纯化疗组和未治疗组在钆布醇增强MRI后齿状核与脑桥信号强度比值。放疗组齿状核与脑桥比值高于未治疗组和单纯化疗组(均P < .01),单纯化疗组与未治疗组间无显著差异(P = .99)。结论认为脑部放疗可独立于大环状钆对比剂给药导致儿童齿状核信号强度增高。

要点

  • 儿童脑肿瘤放疗后齿状核与脑桥信号强度比值较未治疗和单纯化疗患儿升高(均P < .01)。
  • 单纯化疗与未治疗患儿齿状核与脑桥比值无显著差异(P = .99),提示化疗本身未显示该效应。
  • 调整治疗因素后,钆对比剂累积剂量对齿状核与脑桥及苍白球与丘脑比值无剂量依赖效应(P = .21和P = .38)。

核心结论

  • 儿童脑肿瘤患者脑部放疗可独立于大环状钆对比剂给药导致齿状核信号强度增高。

研究设计与样本

  • 回顾性单中心研究纳入78例原发性脑肿瘤患儿(平均年龄7.7岁±5.4),2015至2018年接受大环状钆对比剂增强MRI,比较放疗组37例(其中26例同期化疗)、单纯化疗组17例和未治疗组24例。

关键影像表现/征象

  • 在未增强T1加权图像上测量苍白球、丘脑、齿状核和脑桥的信号强度。
  • 放疗组齿状核与脑桥信号强度比值高于未治疗组和单纯化疗组(均P < .01)。
  • 单纯化疗组与未治疗组齿状核与脑桥比值无显著差异(P = .99)。
  • 三组间苍白球与丘脑比值无差异(P = .09)。

诊断标准与关键数值

  • 放疗组、单纯化疗组和未治疗组平均钆对比剂增强MRI检查次数分别为7.11次、7.29次和4.96次(放疗组和化疗组与未治疗组比较P < .01)。
  • 调整治疗效应后,钆对比剂对齿状核与脑桥比值及苍白球与丘脑比值无剂量依赖效应(分别为P = .21和P = .38)。

临床应用与阅片要点

  • 阅片时可将齿状核与脑桥信号强度比值作为儿童脑肿瘤放疗后随访的观察指标之一。
  • 报告时需结合放疗史解读齿状核T1信号增高,注意其独立于大环状钆对比剂给药。
  • 单纯化疗患儿未见齿状核与脑桥比值升高,组间比较时需注意治疗分组差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine whether treatment affects MRI signal intensity in pediatric patients with primary brain tumors independent of the administration of macrocyclic gadolinium-based contrast agents (GBCAs). Materials and Methods This retrospective, single-center study included 78 patients (mean age, 7.7 years ± 5.4) with primary brain tumors who underwent macrocyclic GBCA-enhanced MRI from 2015 to 2018. Three groups were compared: (a) patients who had undergone radiation therapy (37 patients, 26 of whom had undergone concurrent chemotherapy), (b) patients who had undergone chemotherapy only (17 patients), and (c) patients who had received no treatment ("no-treatment group," 24 patients). The signal intensity in the globus pallidus (GP), thalamus, dentate nucleus (DN), and pons was measured on unenhanced T1-weighted images. GP-to-thalamus and DN-to-pons signal intensity ratios were compared among groups with analysis of variance by using the Kruskal-Wallis test, followed by post hoc pairwise tests with Tukey adjustment, and were analyzed relative to group, total cumulative doses of GBCA, age, and sex with multivariable linear models. Results The mean number of GBCA-enhanced MRI examinations in the radiation therapy, chemotherapy-only, and no-treatment groups was 7.11, 7.29, and 4.96, respectively (P < .01 for the radiation therapy and chemotherapy groups compared with the no-treatment group). The DN-to-pons ratio in the radiation therapy group was higher than that in both the no-treatment group and the chemotherapy-only group (P < .01 for both). There was no significant difference in the DN-to-pons ratios between the chemotherapy-only group and the no-treatment group (P = .99). The GP-to-thalamus ratios did not differ among all three groups (P = .09). There was no dose-dependent effect of GBCA on the DN-to-pons and GP-to-thalamus ratios when adjusting for the effects of treatment (P = .21 and P = .38, respectively). Conclusion Brain irradiation contributes to a higher dentate nucleus signal intensity in pediatric patients with brain tumor independent of the administration of macrocyclic gadolinium-based contrast agents. © RSNA, 2018.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Tamrazi B, Liu CJ, Cen SY, et al. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity. Radiology. 2018. PMID: 29989524. doi:10.1148/radiol.2018173057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。